Opioid receptor ligand binding in the human striatum: II. Heterogeneous distribution of kappa opioid receptor labeled with [3H]bremazocine

Journal of Comparative Neurology

Volumn 374, Issue 2, 1996, Pages 223-229

  Vonkeman, Harald E ^a,d   Voorn, Pieter ^a,d   Brady, Linda S ^c   Berendse, Henk W ^b,d   Richfield, Eric K ^d  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

basal ganglia; kappa opioid receptor; nucleus accumbens; receptor autoradiography

Indexed keywords

BREMAZOCINE; KAPPA OPIATE RECEPTOR; TRITIUM;

ARTICLE; AUTORADIOGRAPHY; CAUDATE NUCLEUS; CORPUS STRIATUM; HUMAN; HUMAN TISSUE; LIGAND BINDING; NERVE CELL DIFFERENTIATION; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PUTAMEN; RECEPTOR BINDING; RECEPTOR DENSITY; TISSUE DISTRIBUTION;

ADULT; AGED; ANALGESICS; BENZOMORPHANS; BINDING, COMPETITIVE; CORPUS STRIATUM; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, OPIOID, KAPPA;

EID: 0029911474     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9861(19961014)374:2<223::AID-CNE5>3.0.CO;2-4     Document Type: Article

References (43)

1. Bals-Kubik, R., A. Herz, and T.S. Shippenberg (1989) Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated. Psychopharmacology 98:203-206.
2. Bals-Kubik, R., A. Ableitner, A. Herz, and T.S. Shippenberg (1993) Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J. Pharmacol. Exp. Ther. 264:489-495.
3. Berendse, H.W., and E.K. Richfield (1993) Heterogeneous distribution of dopamine D1 and D2 receptors in the human ventral striatum. Neurosci. Lett. 150:75-79.
4. Bot, G., L.A. Chahl, P.J. Brent, and P.A. Johnston (1992) Effects of intracerebroventricularly administered mu-, delta- and kappa-opioid agonists on locomotor activity of the guinea pig and the pharmacology of the locomotor response to U50,488H. Neuropharmacology 31:825-833.
5. Bozarth, M.A., and R.A. Wise (1984) Anatomically distinct opiate receptor fields mediate reward and physical dependence. Science 224:516-517.
6. Brady, L.S., R.B. Rothman, and M. Herkenham (1988) Physiological regulation of neurohypophyseal kappa-opiate receptors. Brain Res. 443:398-402.
7. Cunningham, S.T., and A.E. Kelley (1992) Opiate infusion into nucleus accumbens, contrasting effects on motor activity and responding for conditioned reward. Brain Res. 588:104-114.
8. Di Chiara, G., and A. Imperato (1988) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmaool. Exp. Ther. 244:1067-1080.
9. Goldstein, A., and A. Naidu (1989) Multiple opioid receptors: ligand selectivity profiles and binding site signatures. Mol. Pharmacol. 36:265-272.
10. Heimer, L., and R.D. Wilson (1975) The subcortical projections of the allocortex: similarities in the neural associations of the hippocampus, the piriform cortex, and the neocortex. In M. Santini (ed): Golgi Centennial Symposium. Proceedings. New York: Raven Press, pp. 177-193.
11. Herz, A., and T.S. Shippenberg (1989) Neurochemical aspects of addiction: opioids and other drugs of abuse. In A. Goldstein (ed): Molecular and Cellular Aspects of Drug Addiction. New York: Springer-Verlag, pp. 111-141.
12. Hurd, Y.L., and M. Herkenham (1995) The human neostriatum shows compartmentalization of neuropeptide gene expression in dorsal and ventral regions: an in situ hybridization histochemical analysis. Neuroscience 64:571-586.
13. Kalivas, P.W., E. Widerlov, D. Stanley, G. Breese, and A.J. Prange (1983) Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity. J. Pharmacol. Exp. Ther. 227:229-237.
14. Koob, G.F. (1992) Drugs of Abuse, Anatomy, Pharmacology and Function of Reward Pathways. Trends Pharmacol. Sci. 13:177-184.
15. Lewis, M.E., H. Khachaturian, H. Akil, and S.J. Watson (1984) Anatomical relationship between opioid peptides and receptors in rhesus monkey brain. Brain Res. Bull. 13:801-812.
16. Mansour, A., H. Khachaturian, M.E. Lewis, H. Akil, and S.J. Watson (1987) Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J. Neurosci. 7:2445-2464.
17. Mansour, A., H. Khachaturian, M.E. Lewis, H. Akil, and S.J. Watson (1988) Anatomy of CNS opioid receptors. Trends Neurosci. 11:308-314.
18. Mansour, A., C.A. Fox, H. Akil, and S.J. Watson (1995) Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18:22-29.
19. Maurer, R., R. Cortes, A. Probst, and J.M. Palacios (1983) Multiple opiate receptors in human brain: an autoradiographic investigation. Life Sci. 33:231-234.
20. McGeorge, A.J., and R.L.M. Faull (1989) The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience 29:503-537.
21. McLean, S., R.B. Rothman, and M. Herkenham (1986) Autoradiographic localization of mu- and delta-opiate receptors in the forebrain of the rat. Brain Res. 378:49-60.
22. 3H]U-69593 binding sites in rat brain: evidence for kappa opioid receptor subtypes. Eur. J. Pharmacol. 154:27-34.
23. 3H]muscimol binding in substantia nigra, entopeduncular nucleus, globus pallidus and thalamus after striatal lesions as demonstrated by quantitative receptor autoradiography. J. Neurosci. 3:1189-1198.
24. Parent, A. (1990) Extrinsic connections of the basal ganglia. Trends Neurosci. 13:254-258.
25. Pfeiffer, A., V. Brantl, A. Herz, and H.M. Emrich (1986) Psychotomimesis mediated by kappa opiate receptors. Science 233:774-776.
26. Pilapil, C., S. Welner, J. Magnan, S. Gauthier, and R. Quirion (1987) Autoradiographic distribution of multiple classes of opioid receptor binding sites in human forebrain. Brain Res. Bull. 19:611-615.
27. Rice, K.C., A.E. Jacobson, T.R. Burke, B.S. Bajwa, R.A. Streaty, and W.A. Klee (1983) Irreversible ligands with high selectivity towards μ or κ opioid receptors in the rat forebrain and midbrain. J. Neurosci. 7:2445-2464.
28. Richfield, E.K., A.B. Young, and J.B. Penney (1987) The distribution of D-1 and D-2 dopamine receptors in the basal ganglia of turtles, pigeons, rats, cats, and monkeys. J. Comp. Neurol. 262:446-463.
29. Rothman, R.B., V. Bykov, B.G. Xue, H. Xu, B.R. De Costa, A.E. Jacobson, K.C. Rice, J.E. Kleinman, and L.S. Brady (1992) Interaction of opioid peptides and other drugs with multiple kappa receptors in rat and human brain. Evidence for species differences. Peptides 13:977-987.
30. Sandyk, R. (1985) The endogenous opioid system in neurological disorders of the basal ganglia. Life. Sci. 37:1655-1663.
31. Schoffelmeer, A.N., K.C. Rice, A.E. Jacobson, J.G. Van Gelderen, F. Hogenboom, M.H. Heijna, and A.H. Mulder (1988) Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate. Eur. J. Pharmacol. 154:169-178.
32. Selemon, L.D., and P.S. Goldman-Rakic (1985) Longitudinal topography and interdigitation of corticostriatal projections in the Rhesus monkey. J. Neurosci. 5:776-794.
33. Sharif, N.A., and J. Hughes (1989) Discrete mapping of brain Mu and delta opioid receptors using selective peptides: quantitative autoradiography, species differences and comparison with kappa receptors. Peptides 10:499-522.
34. Shippenberg, T.S., R. Bals-Kubik, and A. Herz (1987) Motivational properties of opioids: evidence that an activation of delta-receptors mediates reinforcement processes. Brain Res. 436:234-239.
35. Spyraki, C., H.C. Fibiger, and A.G. Phillips (1983) Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system. Psychopharmacology 79:278-283.
36. Stinus, L., G.F. Koob, N. Ling, F.E. Bloom, and M. Le Moal (1980) Locomotor activation induced by infusion of endorphins into the ventral tegmental area: evidence for opiate-dopamine interactions. Proc. Natl Acad. Sci. U.S.A. 77:2323-2327.
37. Tempel, A., and R.S. Zukin (1987) Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography. Proc. Natl Acad. Sci. U.S.A. 84:4308-4312.
38. Voorn, P., L.S. Brady, A. Schotte, H.W. Berendse, and E.K. Richfield (1994) Evidence for two neurochemical divisions in the human nucleus accumbens. Eur. J. Neurosci. 6:1913-1916.
39. Voorn, P., Brady, L.S., Berendse, H.W. and E.K. Richfield (1996) Densitometrical analysis of opioid receptor ligand binding in the human striatum: I. distribution of mu opioid receptor defines shell and core of the ventrical striatum. Neuroscience (in press).
40. Wise, R.A. (1983) Brain neuronal systems mediating reward. In J.E. Smith, and J.D. Lane (eds): The Neurobiology of Opiate Reward Processes. Amsterdam: Elsevier Biomedical, pp. 405-428.
41. Yaksh, T.L., and T.A. Rudy (1978) Narcotic analgetics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques. Pain 4:299-359.
42. Yuan, X.R., S. Madamba, and G.R. Siggins (1992) Opioid peptides reduce synaptic transmission in the nucleus accumbens. Neurosci. Lett. 134:223-228.
43. Zukin, R.S., M. Eghbali, D. Olive, E.M. Unterwald, and A. Tempel (1988) Characterization and visualization of rat and guinea pig brain kappa opioid receptors: evidence for kappa 1 and kappa 2 opioid receptors. Proc. Natl Acad. Sci. U.S.A. 85:4061-4065.